NCT03832985 2026-04-09
Pediatric Reporting of Adult-Onset Genomic Results
Geisinger Clinic
Phase EARLY_PHASE1 Completed
Clinical Trials
91 trialsNCT04721886 2026-04-02
Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04278989 2026-03-25
Inhibition of Oral Tumorigenesis by Antitumor B
Medical College of Wisconsin
Phase EARLY_PHASE1 Completed
NCT04188665 2026-03-20
Using MASL to Combat Oral Cancer
Rowan University
Phase EARLY_PHASE1 Completed
NCT03276832 2026-03-19
Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT01804712 2026-03-12
Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy
University of California, San Diego
Phase EARLY_PHASE1 Completed
NCT02603887 2026-01-29
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04018053 2026-01-27
18Fluorine-Fluciclovine PET/CT for Staging Muscle Invasive Bladder Cancer Preceding Radical Cystectomy
Brigham and Women's Hospital
Phase EARLY_PHASE1 Active not recruiting
NCT04825275 2026-01-23
Neuro-pharmacological Properties of Repurposed Posaconazole in Glioblastoma: A Phase 0 Clinical Trial
Milton S. Hershey Medical Center
Phase EARLY_PHASE1 Terminated
NCT05245682 2026-01-08
Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer
Emory University
Phase EARLY_PHASE1 Active not recruiting
NCT04897763 2026-01-07
PERTINENCE
Institut Cancerologie de l'Ouest
Phase EARLY_PHASE1 Completed
NCT02282917 2025-12-05
Exploratory Evaluation of AR-42 Histone Deacetylase Inhibitor in the Treatment of Vestibular Schwannoma and Meningioma
Massachusetts Eye and Ear Infirmary
Phase EARLY_PHASE1 Terminated
NCT04424966 2025-10-24
Infigratinib in Recurrent High-Grade Glioma Patients
St. Joseph's Hospital and Medical Center, Phoenix
Phase EARLY_PHASE1 Terminated
NCT03507608 2025-10-16
Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT04495751 2025-10-16
Muscadine Grape Extract to Improve Fatigue
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Completed
NCT05105087 2025-08-22
Gynecological Sentinel Lymph Nodes CEUS
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT05859971 2025-07-29
ICG and SLN Mapping
University of Wisconsin, Madison
Phase EARLY_PHASE1 Completed
NCT03215095 2025-07-17
RAI Plus Immunotherapy for Recurrent/Metastatic Thyroid Cancers
Memorial Sloan Kettering Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT04678440 2025-07-02
[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients
University of California, Davis
Phase EARLY_PHASE1 Completed
NCT03834740 2025-05-30
A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection
St. Joseph's Hospital and Medical Center, Phoenix
Phase EARLY_PHASE1 Completed
NCT01184885 2025-05-04
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT02896907 2025-04-30
Ascorbic Acid and Combination Chemotherapy in Treating Patients With Locally Advanced or Recurrent Pancreatic Cancer That Cannot Be Removed by Surgery
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT03109873 2025-04-30
Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
NCT04049474 2025-04-24
Bronchoscopic Cryo-Immunotherapy of Lung Cancer
NYU Langone Health
Phase EARLY_PHASE1 Completed
NCT06001372 2025-04-16
TREK
University of Utah
Phase EARLY_PHASE1 Terminated
NCT02827838 2025-03-17
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Terminated
NCT05110495 2025-02-17
WINGMEN
University of Oxford
Phase EARLY_PHASE1 Completed
NCT04883645 2025-01-28
Neoadjuvant Imiquimod Immunotherapy for Oral Cancer
Medical University of South Carolina
Phase EARLY_PHASE1 Completed
NCT03459729 2025-01-16
Pharmacokinetic (PK) Analysis of Antitumor B in Patients With Oral Cancer
Medical College of Wisconsin
Phase EARLY_PHASE1 Completed
NCT03153410 2025-01-09
Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Completed
NCT02901925 2024-12-13
ABY-029
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Completed
NCT02913430 2024-09-23
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
University of Pittsburgh
Phase EARLY_PHASE1 Completed
NCT02415387 2024-07-24
IMPACT
Ohio State University Comprehensive Cancer Center
Phase EARLY_PHASE1 Completed
NCT03132467 2024-06-05
Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed
NCT02981914 2024-04-22
Pilot Study of Pembrolizumab Treatment for Disease Relapse After Allogeneic Stem Cell Transplantation
University of Chicago
Phase EARLY_PHASE1 Completed
NCT03519308 2024-03-15
A Pilot Study of Perioperative Nivolumab and Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer
Abramson Cancer Center at Penn Medicine
Phase EARLY_PHASE1 Terminated
NCT03771157 2024-03-15
Serologic Response to SHINGRIX Vaccine in Patients With CLL and WM Treated With BTK Inhibitors
University of Rochester
Phase EARLY_PHASE1 Completed
NCT02728830 2024-02-21
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
Duke University
Phase EARLY_PHASE1 Completed
NCT04327934 2024-02-02
Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome
Yale University
Phase EARLY_PHASE1 Terminated
NCT01383135 2024-01-12
Biodistribution and Safety of the PET Probes [18F]FPRGD2 and [18F]FPPRGD2
Stanford University
Phase EARLY_PHASE1 Completed
NCT03870529 2024-01-09
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
Wake Forest University Health Sciences
Phase EARLY_PHASE1 Terminated
NCT00736450 2023-10-24
Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
University of Nebraska
Phase EARLY_PHASE1 Terminated
NCT03477162 2023-10-03
Metformin Pharmacology in Human Cancers: A Proof of Principle Study
Dartmouth-Hitchcock Medical Center
Phase EARLY_PHASE1 Terminated
NCT01074814 2023-09-28
Side-Out
Translational Drug Development
Phase EARLY_PHASE1 Completed
NCT02774291 2023-08-04
Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes
Albert Einstein College of Medicine
Phase EARLY_PHASE1 Terminated
NCT03272633 2023-06-26
Irradiated Donor Cells Following Stem Cell Transplant in Controlling Cancer in Patients With Hematologic Malignancies
Rutgers, The State University of New Jersey
Phase EARLY_PHASE1 Terminated
NCT02065609 2022-10-13
89ZrTrastuzumab Breast Imaging With Positron Emission Tomography
Washington University School of Medicine
Phase EARLY_PHASE1 Completed
NCT03020017 2022-08-26
NU-0129 in Treating Patients With Recurrent Glioblastoma or Gliosarcoma Undergoing Surgery
Northwestern University
Phase EARLY_PHASE1 Completed
NCT00978562 2022-08-03
DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Completed
NCT01979003 2022-02-24
Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion
University of Arkansas
Phase EARLY_PHASE1 Completed